« Previous
Next »
Titles
- A comparison of brand-name drug prices among selected federal programs1
- A public option for health insurance in the nongroup marketplaces: key design considerations and implications1
- ACF cannot ensure that all child victims of abuse and neglect have court representation1
- ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin1
- Arthroscopy pump tubing sets intended for multiple patient use - Premarket Notification (510(k)) submissions: guidance for industry and Food and Drug Administration staff1
- Associations between county-level vaccination rates and COVID-19 outcomes among Medicare beneficiaries2
- Availability of supplemental benefits in Medicare Advantage plans in rural and urban areas1
- Awake fiber optic intubation1